CompletedNCT03365362
A Trial of Directly Observed and Long-term Varenicline
Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- The BronxSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 25, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 243
- Sponsor
- Albert Einstein College of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03365362
- Official title
Show the full official title
Achieving Smoking Cessation Milestones in Opioid Treatment Patients: a Randomized 2 x 2 Factorial Trial of Directly Observed and Long-term Varenicline
Get this study by email
Recruitment & locations
CompletedThe Bronx
Questions about this study
Who is behind this study?
The study sponsor is Albert Einstein College of Medicine, a university.
Did this study involve medication?
Yes. The study involved medication, including Long-Term Varenicline and Short-Term Varenicline.
Who was this study for?
Listed age limits: from 18 years.
